Most cases involve patients aged 30 to 80 years with low mortality in healthy individuals where the infection may have an asymptomatic/paucisymptomatic course, recovering from the disease without any special treatment. About one of the six people with COVID-19 become seriously ill, developing life...
Dear Editor, Italian authors published recently in the journal of Dermatologic Therapy their recommendations for treatment of patients with psoriasis at time of new COVID-19 pandemic. The authors pointed to the importance of therapeutic reassessment of all psoriatic patients, particularly those with ...
Arterial hypertension is a common comorbidity of moderate-severe psoriasis, and in our relatively young patient, we did not deem this sufficient to interrupt treatment with ixekizumab for the risk of SARS-CoV-2 infection.doi:10.1111/ijd.15008Paola Facheris...
[9]Olisova OY, Anpilogova EM, Svistunova DA. Apremilast as a potential treatment option for COVID-19: No symptoms of infection in a psoriatic patient. Dermatol Ther. 2020;33(4):e13668. [10]Schafer P. Apremilast mechanism...
Ideally, ultraviolet (UV) light ranging between 240 and 280 nm is used for disinfection purposes, while between 300 and 320 nm is used in medicinal applications, like in phototherapy for psoriasis or mycosis fungoides.259,260 UV exposure from a far-off source has an antimicrobial function, unde...
While more research is needed, it is reassuring to know that successful recovery is possible after COVID-19 infection in patients on biologic therapy for psoriasis. 展开 关键词: Biologics COVID-19 Infection Pandemic Psoriasis SARS-CoV-2 Virus ...
(e.g., lesion size in dermatology or plaque psoriasis). Though investigators recognized the potential to collect other measures via telehealth (e.g., depression scales), they expressed concern that the method is not validated and requires proof of concept before regulators would accept d...
In relation to immune-mediated diseases with dermatologic manifestations, cases of flare-ups of psoriasis and latent forms have been described; thyroiditis, new-onset diabetic ketoacidosis (in the absence of a previous diagnosis of diabetes mellitus). Cardiovascular and hematologic symptoms may occur ...
expressed by people who are living with psoriasis. The PsoProtect registry is vital in helping us understand more about the interactions between psoriasis, its treatments and COVID-19 infection so patients can make the most informed choices about their care and treatment at this challenging time."...
While specific data on nail psoriasis treatments and COVID-19 is lacking, we present clinical trial data on rates of upper respiratory infections, nasopharyngitis, viral infection, pneumonia and overall infections. Some systemic medications and biologics are associated with increased in infections risk ...